drugset / Trial / NCT03168334
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.
Timeline
- Start
- 2017-07-11
- Primary completion
- 2018-07-24
- Completion
- 2018-07-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tazarotene | Small molecule | 0.045 % | — |